Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. - Wikidata - awgldk - TriplyDB

Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.

Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.

http://www.wikidata.org/entity/Q34576082

about

Roselle for hypertension in adults Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report Anti-hypertensive Herbs and their Mechanisms of Action: Part I Hibiscus sabdariffa L., roselle calyx, from ethnobotany to pharmacology.The Effect of Anthocyanins on Blood Pressure: A PRISMA-Compliant Meta-Analysis of Randomized Clinical Trials Chinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of Action Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes Anti-hepatotoxic activities of Hibiscus sabdariffa L. in animal model of streptozotocin diabetes-induced liver damage.Cardiac and Vascular Synergic Protective Effect of Olea europea L. Leaves and Hibiscus sabdariffa L. Flower Extracts.Identification and Characterization of Roseltide, a Knottin-type Neutrophil Elastase Inhibitor Derived from Hibiscus sabdariffa.Review of existing experimental approaches for the clinical evaluation of the benefits of plant food supplements on cardiovascular function.Inhibition of Angiotensin Converting Enzyme, Angiotensin II Receptor Blocking, and Blood Pressure Lowering Bioactivity across Plant Families.Multi-Targeted Molecular Effects of Hibiscus sabdariffa Polyphenols: An Opportunity for a Global Approach to Obesity.Aqueous extract of dioscorea opposita thunb. normalizes the hypertension in 2K1C hypertensive rats In vitro vasorelaxation mechanisms of bioactive compounds extracted from Hibiscus sabdariffa on rat thoracic aorta The Labdane Ent-3-Acetoxy-Labda-8(17), 13-Dien-15-Oic Decreases Blood Pressure In Hypertensive Rats.Effects of anthocyanins on blood pressure and stress reactivity: a double-blind randomized placebo-controlled crossover study.Inhibitory effects of aqueous extract of Hibiscus sabdariffa on contractility of the rat bladder and uterus.Clinical efficacy of African traditional medicines in hypertension: A randomized controlled trial with Combretum micranthum and Hibiscus sabdariffa.Herbs Used for the Treatment of Hypertension and their Mechanism of Action.Roselle Polyphenols Exert Potent Negative Inotropic Effects via Modulation of Intracellular Calcium Regulatory Channels in Isolated Rat Heart.Proteinease inhibition, membrane stabilization, antioxidant and phytochemical evaluations of leaves, seeds and calyces of four selected edible medicinal plants

P2860

Q24241036-B7777B9B-75E0-4A4F-A3C2-A616F02918A5 Q24647828-9096F875-B8FA-467E-87FC-3BCD852A886F Q26772791-095656D6-D1D6-4256-8811-AD935C2041E2 Q27686933-1AE0055C-F23B-4334-B33F-EEE089B6EE7B Q28070361-6613F415-55AF-42D2-8EEA-92F2DCA160CD Q28072623-E7502F93-2E54-4EE6-93C5-F1E4C01296E2 Q28283749-D1FB0343-844B-4CB2-B82A-BFC85F128566 Q28289994-6A32F844-69F2-4331-A63B-0C532E85BB2C Q34037682-DED93711-EE39-4EBD-A444-E4C5743E2AA0 Q35768990-F25F2FCA-678A-443D-8F61-F3F12C304D7F Q37518852-3AE40D1A-900A-409F-9DC4-C559CD4E4F5C Q38106817-622785C6-4F46-4C0E-8197-B17F84E14195 Q38219179-CEEC4459-9FF2-478F-BE8D-545A8F0A3D7B Q41584436-672A693B-37DC-4549-A2F7-E92E8AB4E876 Q41895182-EE9CF55F-E074-46D8-98BC-C422CB0B54E4 Q41947843-67397234-2698-49A1-B834-56F0269DE3CF Q42426281-19337813-92A2-491B-8BEE-5011588F467D Q44265293-25C39F97-5F3E-4694-9DFC-CE753C3853EA Q46777877-0ED88B4B-6587-4742-B70C-B91AE3749314 Q47195007-35689039-4E87-4808-B21E-2202DEA20300 Q50047464-918B8390-1DEC-44A3-9D0F-B97990308108 Q53734108-0BF6E1EF-8289-486F-895A-A97FD63CFB77 Q59313291-E73B5BE6-A36C-4A6E-9F4A-6E387E4C7D53

P2860

Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.

http://www.wikidata.org/entity/Q34576082

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Clinical effects produced by a ...... ril-controlled clinical trial.

@ast

Clinical effects produced by a ...... ril-controlled clinical trial.

@en

Clinical effects produced by a ...... ril-controlled clinical trial.

@nl

type

label

Clinical effects produced by a ...... ril-controlled clinical trial.

@ast

Clinical effects produced by a ...... ril-controlled clinical trial.

@en

Clinical effects produced by a ...... ril-controlled clinical trial.

@nl

prefLabel

Clinical effects produced by a ...... ril-controlled clinical trial.

@ast

Clinical effects produced by a ...... ril-controlled clinical trial.

@en

Clinical effects produced by a ...... ril-controlled clinical trial.

@nl

P1433

Q34576082-0F92AE7E-D089-40B8-9678-47BCED7D8CEE

P1476

Q34576082-85C5C79D-8A71-46CB-8602-FCE4A563C9BC

P2093

Q34576082-06109F50-66C8-428D-9A52-F2D272207DFD

Q34576082-85FC22FB-2DA3-4132-B075-8707D83EE7C9

Q34576082-99ED1636-9A5F-4D52-B597-9491A6D74FC8

Q34576082-AB736905-64D1-41FE-8289-553B540E50F3

Q34576082-ACBE6357-D809-4F32-AAF2-C6EE47D7A9B2

Q34576082-B4D0E88E-73B8-42F4-95CA-0E41AFC10B7C

Q34576082-CD22393C-D330-4C48-8622-C58215A9C193

Q34576082-DCAC4481-7107-41CB-9E0B-C63649518BC5

Q34576082-E6B92C0D-6D6A-4331-9B77-18A654ABE2D8

P304

Q34576082-B6DFF7B6-64C1-407E-8F0B-9E633027D486

P31

Q34576082-DDBE8020-813B-434E-AB8E-A84D3BCC5001

P356

Q34576082-2B15A6A8-F5D4-44B9-BD46-52F133E8352C

P433

Q34576082-5F961E9C-32A6-4F9F-A7BC-A4C9DBEE7E2A

P478

Q34576082-CC62F9F2-ECEA-45DA-B2E5-62990C9426FF

P577

Q34576082-6219BE43-8F8B-4A32-9A8E-9BEAF10D8189

P5875

Q34576082-35EE23E5-C38F-4BF3-A64A-D4A5B315293F

P698

Q34576082-261CFF70-0A60-45ED-98C5-88353871DC1B

P356

P1433

P1476

Clinical effects produced by a ...... ril-controlled clinical trial.

@en

P2093

Alejandro Zamilpa

http://www.w3.org/2001/XMLSchema#string

Armando Herrera-Arellano

http://www.w3.org/2001/XMLSchema#string

Héctor Ponce-Monter

http://www.w3.org/2001/XMLSchema#string

Jaime Tortoriello

http://www.w3.org/2001/XMLSchema#string

Jesús Enrique Jiménez-Ferrer

http://www.w3.org/2001/XMLSchema#string

Judith Miranda-Sánchez

http://www.w3.org/2001/XMLSchema#string

Pedro Avila-Castro

http://www.w3.org/2001/XMLSchema#string

Rubén Román-Ramos

http://www.w3.org/2001/XMLSchema#string

Sara Herrera-Alvarez

http://www.w3.org/2001/XMLSchema#string

P304

6-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-2006-957065

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6491226

http://www.w3.org/2001/XMLSchema#string

P698

17315307

http://www.w3.org/2001/XMLSchema#string